Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
2.110
-0.200 (-8.66%)
At close: Nov 19, 2026, 4:00 PM EST
2.100
-0.010 (-0.47%)
After-hours: Nov 19, 2026, 6:59 PM EST
Veru Inc. Employees
Veru Inc. had 20 employees as of September 30, 2025. The number of employees decreased by 190 or 90.48% compared to the previous year. That makes Veru Inc. the 38,500th largest employer in the world and 5,525th in the United States.
Employees
20
Change (1Y)
-190
Growth (1Y)
-90.48%
Revenue / Employee
n/a
Profits / Employee
-$680,428
Market Cap
35.98M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 20 | -190 | -90.48% | 20 | 0 |
| Sep 30, 2024 | 210 | 21 | 11.11% | 210 | 0 |
| Sep 30, 2023 | 189 | -44 | -18.88% | 189 | 0 |
| Sep 30, 2022 | 233 | -19 | -7.54% | 233 | 0 |
| Sep 30, 2021 | 252 | -87 | -25.66% | 252 | 0 |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Alps Group | 93 |
| MindWalk Holdings | 77 |
| Pliant Therapeutics | 49 |
| Biomea Fusion | 37 |
| Instil Bio | 17 |
| Apollomics | 14 |
| Eloxx Pharmaceuticals | 10 |
| Hyperion DeFi | 9 |
VERU News
- 2 days ago - Veru Presents New Results at ObesityWeek 2026: GLP-1 Weight Loss in Older Adults Associated with Physical Function Decline; Adding Enobosarm Preserved Significant Lean Mass and Physical Function - GlobeNewsWire
- 10 days ago - Veru to Present New Results on Effects of Enobosarm on Physical Function in Older Patients Receiving GLP-1 RA from the Phase 2b QUALITY clinical study at ObesityWeek 2026 - GlobeNewsWire
- 6 weeks ago - Veru initiated with a Buy at WestPark Capital - TheFly
- 2 months ago - Veru Inc. Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 2 months ago - Veru Inc. Slides: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Filings
- 2 months ago - Veru adavances sabizabulin following preclinical data - TheFly
- 2 months ago - Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines' RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial - GlobeNewsWire
- 2 months ago - Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference - GlobeNewsWire